|
|
||||||||
1 From the National Institute of Public Health, Cuernavaca, Mexico; 2 Environmental Research Center and Department of Anesthesiology, Charles R. Drew University of Medicine and Science, Los Angeles, California; the 3 National Institute of Perinatology, Mexico City, Mexico; the 4 U.S. Environmental Protection Agency, Division of Neurotoxicology, Research Triangle Park, North Carolina; and 5 College of Optometry, Departments of Biology and Biochemistry, and Pharmacology and Pharmaceutical Sciences, University of Houston, Houston, Texas.
PURPOSE. To determine the doseresponse relationship between blood lead concentration ([PbB]) and scotopic ERG amplitude in 7- to 10-year-old children with lifetime lead exposure.
METHODS. Full-field flash scotopic ERGs were recorded over a 4-log-unit range in 45 dark-adapted children with normal visual acuity. [PbB] was measured throughout pregnancy and postnatal development, and the subjects [PbB] levels were grouped at each age by tertiles.
RESULTS. The median [PbB] during pregnancy was, from lowest to highest tertile, 2.5 to 5.0, 7.5 to 9.0, and 14.0 to 16.5 µg/dL, and after birth was 4.0 to 8.0, 6.0 to 14.5, and 7.5 to 21.0 µg/dL. Only maternal [PbB] at 12 weeks of pregnancy showed a significant doseresponse relationship with the ERG measures, so that with increasing [PbB] there were significant increases in leading-edge a-wave amplitude, peak a-wave amplitude, and b-wave amplitude and sensitivity, with no changes in implicit times. Data analyses showed that children whose mothers had [PbB] of 10.5 µg/dL or more at 12 weeks of pregnancy had relatively increased a- and b-waves.
CONCLUSIONS. Lead exposure during the first trimester of pregnancy produces dose-dependent increases in scotopic a- and b-wave amplitudes in 7- to 10-year-old children. The results suggest that the increases in a- and b-wave amplitudes originate from rods; however, the increased b-wave amplitude and sensitivity may also originate in the inner retina. These alterations occurred at maternal [PbB] at or below currently accepted safe levels. These novel findings reveal that the developing retina is a sensitive target for lead and suggest that lead-exposed children be examined for possible future visual system deficits.
This article has been cited by other articles:
![]() |
G. Rischitelli, P. Nygren, C. Bougatsos, M. Freeman, and M. Helfand Screening for Elevated Lead Levels in Childhood and Pregnancy: An Updated Summary of Evidence for the US Preventive Services Task Force Pediatrics, December 1, 2006; 118(6): e1867 - e1895. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. He, G. A. Perkins, A. T. Poblenz, J. B. Harris, M. Hung, M. H. Ellisman, and D. A. Fox Bcl-xL overexpression blocks bax-mediated mitochondrial contact site formation and apoptosis in rod photoreceptors of lead-exposed mice PNAS, February 4, 2003; 100(3): 1022 - 1027. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |